This Article has been retracted by the Editors and Publishers of Scientific Reports. Following online criticisms of the published paper, an investigation at the journal has confirmed the manipulation and duplication of data and a level of image processing that is not compliant with the journal’s policies on image data integrity in figures 1–3, 6, 7, 10 and 12. Versions of figures 1–11 and large sections of the text had also previously been published1,2.
All authors acknowledge these issues and agree to the retraction of the Article.
References
Samie, N. et al. Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells. Front. Pharmacol. 6, 313 (2016). 10.3389/fphar.2015.00313
Samie, N., Muniandy, S., Kanthimathi, M. S. & Haerian, B. S. Mechanism of action of novel piperazine containing a toxicant against human liver cancer cells. PeerJ 4, e1588 (2016). 10.7717/peerj.1588
Additional information
The online version of the original article can be found at 10.1038/srep24172
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Samie, N., Muniandy, S., Kanthimathi, M. et al. Retraction Note: Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties. Sci Rep 6, 29056 (2016). https://doi.org/10.1038/srep29056
Published:
DOI: https://doi.org/10.1038/srep29056
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.